Category: Medical
In recent years, there have been deaths allegedly linked to the use of Medtronic infusion pumps
Since its introduction into the market, the Medtronic infusion pump has been apparently overwhelmed with problems.
In recent years, problems that have been linked to the use of the pumps have reportedly caused dozens of deaths. As such, health authorities and the manufactures are in the process of taking appropriate action, and we’ll be looking in to whether there is any negligence here.
Continue Reading…
Sandwell and West Birmingham NHS Pelvic Floor Prolapse recall – we’re still taking cases forward
Birmingham surgeon Dr. Angamuthu Arunkalaivanan performed hundreds of the pelvic floor surgeries using a mesh implant that the Trust he worked for had banned from using.
Dr. Arunkalaivanan seemingly ignored the Trust’s instructions and carried on inserting these mesh implants into hundreds of women despite the warnings from the National Institute for Health and Care Excellence (NICE) of incontinence and infection, and his own Trust’s policy on their use.
Some 200 patients who have undergone pelvic floor surgeries with Dr. Arunkalaivanan have been recalled to be checked. However, pelvic floor operations are so routine that it may be many more than 200 woman affected by the surgeons actions.
Continue Reading…
Xarelto drug reportedly causing internal bleeding and one death a week
A stern warning for all patients prescribed the blood-thinning drug Rivaroxaban; sold under the name of Xarelto, that’s available on the NHS:
“Medical device battery fault that have caused two deaths” – Battery defects of the implantable cardioverter defibrillators and cardiac resynchronisation therapy devices causing an adverse effect on patients
Due to a battery issue, medical equipment like implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy devices (CRT-D) have reportedly failed, leading to serious concerns for patient health.
It’s thought that around 350,000 devices worldwide have been implanted and potentially put patient health at risk.
Continue Reading…
“Drugs that can give you mood swings” – Reports suggest that beta-blockers and calcium antagonists are medications that can lead to hospitalised mood disorders
Recent reports indicate that individuals taking medication known as beta-blockers and calcium antagonists for a period of more than 90 days may be susceptible to mood disorders that require hospital treatment.
These medications – commonly used to control blood pressure – are said to be a possible cause for major depression and / or bipolar disorder, drawn from comparisons with patients controlling their high blood pressure with angiotensin receptor blockers (ARBs) instead.
Continue Reading…
“Progestogen-only Pill Drug Recalls” – Teva UK Ltd has recalled drugs due to impurities showing in their routine testing
Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs.
The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company to ensure the safety of their customers.
However, as with any medicine recall, the dangers to human health are always something to closely monitor.
Continue Reading…
“The Deadly Stockert 3T Machine” – LivaNova machines that have allegedly caused dozens of patients to develop a mycobacterial infection
There are growing concerns surrounding the use of a particular type of heater-cooler system, Stockert 3T, manufactured by LivaNova, which are machines used during a patient’s surgery that have allegedly led to a spate of infections.
This was reportedly the case for Kenneth Piechowski, a Philadelphia man, when he had a surgery to replace a faulty aortic valve back in December 2014.
Continue Reading…
Tracheoesophageal voice devices are thought to only last three months
Tracheoesophageal voice devices have been reported to have a smaller life span than first anticipated.
What was thought to be at least a six month life span recently turned out to be only three months. This is a cause for concern as it could cause greater healthcare costs and a burden for the users who need to keep replacing them.
Continue Reading…
Accu-Chek Insight insulin pump system prone to insulin leaks – risk of hyperglycaemia
A Medical Device Alert has been issued with the Medicines and Healthcare products Regulatory Agency (MHRA) for the Accu-Chek Insight insulin pump system using NovoRapid PumpCart cartridges which is reportedly prone to leakage.
Leakage of the devices, manufactured by Roche Diabetes Care, could lead to serious consequences for users, which could include hyperglycaemia, diabetic ketoacidosis, or even death.
Continue Reading…
Class 2 medicines recall – Respontin Nebules
Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing.
The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the drugs that have been reported.
But we all know how serious such small problems with medicines and medical products can be. Our Group Action Lawyers have been fighting for the rights of medical group cases for years, so know all too well how bad things can get…
Continue Reading…
Medical Device Alert – Blood glucose monitors
Blood glucose monitors that are for home use are at risk of producing false low blood glucose level results.
It is the TRUEresult and TRUEtrack blood glucose test strips that are possibly producing these false results, which has triggered an MHRA Medical Device Alert.
If you use these devices, you should take heed of this warning, and contact a medical professional or doctor if you are concerned.
Continue Reading…
SerenoCem Ear Cement and Granules – risk of bone reabsorbtion
UPDATE: PLEASE NOTE THAT WE ARE NO LONGER ABLE TO ACCEPT NEW CASES IN THIS MATTER.
Corinthian Surgical Ltd issued a Field Safety Notice in March 2016 about bone reabsorbtion around granules implanted in the middle ear. Patients that were implanted with SerenoCem Granules for destruction of the mastoid cavity are possibly affected.
Patients did not show any symptoms, but reabsorbtion showed up on a CT scan. The reabsorbtion varied from being limited to extensive.
There are clinical risks associated with bone reabsorbtion in the middle ear such as inflammation (that can be infective), which can lead to infection and inflammation of the middle posterior fossa dura, facial nerve, and the inner ear. This can lead to more serious risk such as meningitis, loss of hearing, and facial palsy. However there have been no report of these complications.
Continue Reading…